Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Patel

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
The Journal of Cell Biology|November 7, 2025
Direct measurements of luminal Ca2+ with endo-lysosomal GFP-aequorin reveal functional IP3 receptorsBelén Calvo, Patricia Torres-Vidal, Alba Delrio-Lorenzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
The Journal of General Virology|March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansMatilu Mwau, Inese Cebere, Julian Sutton, et al.
The Journal of Cell Biology|April 25, 2025
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson's diseaseMartina Gregori, Gustavo J S Pereira, Robert Allen, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)Jair Bar, Nir Peled, Shiruyeh Schokrpur, et al.
Elife|March 14, 2020
Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal functionSusanne Gerndt, Cheng-Chang Chen, Yu-Kai Chao, et al.
Nature Communications|November 10, 2019
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's diseaseJulia Benkert, Simon Hess, Shoumik Roy, et al.
Nature Communications|February 2, 2019
Remodeling of secretory lysosomes during education tunes functional potential in NK cellsJodie P Goodridge, Benedikt Jacobs, Michelle L Saetersmoen, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
The Journal of Cell Biology|November 7, 2025
Direct measurements of luminal Ca2+ with endo-lysosomal GFP-aequorin reveal functional IP3 receptorsBelén Calvo, Patricia Torres-Vidal, Alba Delrio-Lorenzo, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
The Journal of General Virology|March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansMatilu Mwau, Inese Cebere, Julian Sutton, et al.
The Journal of Cell Biology|April 25, 2025
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson's diseaseMartina Gregori, Gustavo J S Pereira, Robert Allen, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2023
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapyMingjia Li, Songzhu Zhao, Gabrielle Lopez, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)Jair Bar, Nir Peled, Shiruyeh Schokrpur, et al.
Elife|March 14, 2020
Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal functionSusanne Gerndt, Cheng-Chang Chen, Yu-Kai Chao, et al.
Nature Communications|November 10, 2019
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's diseaseJulia Benkert, Simon Hess, Shoumik Roy, et al.
Nature Communications|February 2, 2019
Remodeling of secretory lysosomes during education tunes functional potential in NK cellsJodie P Goodridge, Benedikt Jacobs, Michelle L Saetersmoen, et al.
Pageof 20